CJC-1295 / Ipamorelin vs PT-141
CJC-1295 / Ipamorelin and PT-141 come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do CJC-1295 / Ipamorelin and PT-141 differ?
CJC-1295 / Ipamorelin (Co-formulated GHRH-analog and secretagogue blend) is catalogued under longevity & cellular research; PT-141 (Synthetic cyclic heptapeptide melanocortin agonist) is catalogued under skin & glow research. Verve lists 5 reported research applications for CJC-1295 / Ipamorelin and 5 for PT-141. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | CJC-1295 / Ipamorelin | PT-141 |
|---|---|---|
| compound class | Co-formulated GHRH-analog and secretagogue blend | Synthetic cyclic heptapeptide melanocortin agonist |
| research area | longevity & cellular | skin & glow |
| reported research applications | 5 listed | 5 listed |
| supplied as | co-formulated blend | single compound |
| catalog sizes | 10mg | 10mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | not offered |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $157.49 | $50.49 |
| availability | in stock | out of stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is CJC-1295 / Ipamorelin and what is PT-141?
CJC-1295 / Ipamorelin is classified as Co-formulated GHRH-analog and secretagogue blend; PT-141 as Synthetic cyclic heptapeptide melanocortin agonist. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
CJC-1295 / Ipamorelin
Co-formulated GHRH-analog and secretagogue blend
CJC-1295 / Ipamorelin is a co-formulated research blend of two peptides that act at separate receptors. CJC-1295 without DAC, also referred to as Mod GRF 1-29, is a modified 29-amino-acid analog of growth-hormone-releasing hormone characterized as a GHRH-receptor agonist. Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the growth-hormone secretagogue receptor, GHS-R1a.
full CJC-1295 / Ipamorelin profile →PT-141
Synthetic cyclic heptapeptide melanocortin agonist
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide analog of the melanocortin family, structurally related to alpha-melanocyte-stimulating hormone and to the earlier research analog Melanotan II. Verve supplies it as a high-purity research compound for laboratory melanocortin-receptor research.
full PT-141 profile →Which research models is each compound studied in?
CJC-1295 / Ipamorelin sits in longevity & cellular research and PT-141 in skin & glow research, so their listed models largely do not intersect. The table lists 5 reported research applications for CJC-1295 / Ipamorelin and 5 for PT-141. Rows are per compound, not equivalences.
| CJC-1295 / Ipamorelin — reported research applications | PT-141 — reported research applications |
|---|---|
| Dual-pathway GHRH-receptor and GHS-R1a signaling research | Melanocortin-receptor (MC1R/MC3R/MC4R) binding research |
| Receptor cross-talk and signal-transduction research models | cAMP and G-protein-coupled receptor signaling assays |
| Comparative agonist research versus single-component preparations | Receptor-selectivity and structure–activity profiling |
| Endocrine-signaling research in cellular and pre-clinical models | MC1R and melanogenesis research models in cell culture |
| Peptide stability and analog structure–activity research | Cyclic-peptide stability and conformation research |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for CJC-1295 / Ipamorelin and PT-141?
CJC-1295 / Ipamorelin is listed from $157.49 and PT-141 from $50.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| CJC-1295 / Ipamorelin | 10mg | $157.49 | in stock |
| PT-141 | 10mg | $50.49 | out of stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about CJC-1295 / Ipamorelin and PT-141
What is CJC-1295 / Ipamorelin?
It is a co-formulated research blend of CJC-1295 without DAC (also called Mod GRF 1-29), a GHRH analog, and ipamorelin, a selective GHS-R1a agonist. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is the difference between CJC-1295 with and without DAC?
The DAC (drug affinity complex) modification is a chemical addition studied for its effect on the analog's circulating half-life in pre-clinical models. The no-DAC form, Mod GRF 1-29, lacks that modification and is the component used in this blend.
What is PT-141?
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide melanocortin analog structurally related to alpha-MSH. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is PT-141 studied for in research?
It is used as a reference agonist in melanocortin-receptor research, including MC1R, MC3R, and MC4R binding studies, cAMP signaling assays, and receptor-selectivity profiling. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.